PMK Ethyl Glycidate

The following information was compiled in December 2024 and is subject to change as new research is conducted and as new information becomes available:

Description: PMK ethyl glycidate is a precursor in the synthesis of methylenedioxyphenethylamines and methylenedioxyamphetamines (e.g., MDMA). PMK ethyl glycidate is structurally similar to PMK methyl glycidate and PMK glycidic acid. PMK ethyl glycidate was identified in seized drug material in Canada in 2023.¹ PMK ethyl glycidate was identified in the United States in July 2024 at our laboratory and confirmed after acquiring standard reference material.

Sample Source: Chicago Recovery Alliance (Chicago, IL)

Sample Appearance: Purple crystalline material

Pharmacology: No information is available at this time.

Toxicology: PMK ethyl glycidate is not currently tested for in toxicology cases at the CFSRE.

Drug Materials: PMK ethyl glycidate has been detected in one drug material to date at the CFSRE.

Demographics / Geographics: The drug material positive for PMK ethyl glycidate originated from the Illinois and was identified alone without the presence of other drugs.

Legal Status: PMK ethyl glycidate is not currently controlled in the United States.

Class:

Miscellaneous

Appearance:

Purple crystalline material

Formula:

C13H14O5

MW:

250.3

[M+]:

250

[M+H]+:

251.0914

IUPAC:

ethyl 3-(1,3-benzodioxol-5-yl)-2-methyl-oxirane-2-carboxylate

Report Date:

December 13, 2024